Cargando…

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization

Tuberculosis (TB) is an infectious disease resulting in millions of deaths annually worldwide. TB treatment is challenging due to a huge number of global latent infections and due to multidrug-resistant forms of TB. Inhaled administration of anti-TB drugs using dry powder inhalers has various advant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eedara, Basanth Babu, Fan, Claire, Sinha, Shubhra, Khadka, Prakash, Das, Shyamal C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536221/ https://www.ncbi.nlm.nih.gov/pubmed/37765321 http://dx.doi.org/10.3390/pharmaceutics15092354

Ejemplares similares

Dissolution and Absorption of Inhaled Drug Particles in the Lungs
por: Eedara, Basanth Babu, et al.
Publicado: (2022)

Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization
por: Momin, Mohammad A. M., et al.
Publicado: (2021)

A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation
por: Khadka, Prakash, et al.
Publicado: (2022)

A STELLA simulation model for in vitro dissolution testing of respirable size particles
por: Eedara, Basanth Babu, et al.
Publicado: (2019)

Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies
por: Momin, Mohammad A. M., et al.
Publicado: (2019)

Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
por: Saha, Tushar, et al.
Publicado: (2022)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices
por: Saha, Tushar, et al.
Publicado: (2022)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery
por: Ruiz, Victor H., et al.
Publicado: (2022)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Spray Dried Formulations for Inhalation—Meaningful Characterisation of Powder Properties
por: Jüptner, Angelika, et al.
Publicado: (2019)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection
por: Eedara, Basanth Babu, et al.
Publicado: (2021)

Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery
por: Rashid, Md Abdur, et al.
Publicado: (2019)

Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations
por: Pardeshi, Sagar R., et al.
Publicado: (2022)

Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
por: Party, Petra, et al.
Publicado: (2021)

Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis
por: Shao, Zitong, et al.
Publicado: (2023)

Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
por: Debnath, Sujit Kumar, et al.
Publicado: (2018)

POxylated Dendrimer‐Based Nano‐in‐Micro Dry Powder Formulations for Inhalation Chemotherapy
por: Restani, Rita B., et al.
Publicado: (2018)

The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics
por: Abiona, Olaitan, et al.
Publicado: (2022)

Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
por: Knap, Karolina, et al.
Publicado: (2022)

Innovative Rocuronium Bromide Topical Formulation for Targeted Skin Drug Delivery: Design, Comprehensive Characterization, In Vitro 2D/3D Human Cell Culture and Permeation
por: Ruiz, Victor H., et al.
Publicado: (2023)

The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
por: Benke, Edit, et al.
Publicado: (2021)

Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
por: Salem, HF, et al.
Publicado: (2011)

Development of an Inhaled Sustained Release Dry Powder Formulation of Salbutamol Sulphate, an Antiasthmatic Drug
por: Kumaresan, C., et al.
Publicado: (2016)

Amorphicity and Aerosolization of Soluplus-Based Inhalable Spray Dried Powders
por: Adhikari, Bishal Raj, et al.
Publicado: (2022)

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
por: Stass, Heino, et al.
Publicado: (2013)

An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma
por: Zatta, Kelly Cristine, et al.
Publicado: (2018)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018)

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
por: Cheng, Shen Nam, et al.
Publicado: (2020)

State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization
por: Groß, Roman, et al.
Publicado: (2022)

Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research
por: Chan, Ho Wan, et al.
Publicado: (2023)

Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation
por: Eedara, Basanth Babu, et al.
Publicado: (2021)

Spray-Dried Inhalable Powder Formulations of Gentamicin Designed for Pneumonic Plague Therapy in a Mouse Model
por: Zhu, Menghuan, et al.
Publicado: (2022)

Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection
por: Saha, Tushar, et al.
Publicado: (2023)

Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions
por: Sabuj, Mohammad Zaidur Rahman, et al.
Publicado: (2022)

Inhalational System for Etoposide Liposomes: Formulation Development and In Vitro Deposition
por: Parmar, J. J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_26mtvje2v21e366m9tgsdoe6mi